| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/11/2012 | EP1438586B1 Fret protease assays for clostridial toxins |
| 01/11/2012 | EP1402070B1 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 01/11/2012 | EP1401497B1 Methods for the modulation of il-13 |
| 01/11/2012 | EP1370288B1 Method for treating thrombocytopenia with monoclonal ivig |
| 01/11/2012 | EP1334659B1 Pd-1-lacking mouse and use thereof |
| 01/11/2012 | EP1019432B1 The ob receptor and methods of diagnosing and treating weight |
| 01/11/2012 | EP0975672B1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 01/11/2012 | CN1934134B Methods for inducing autolysis in infectious bacteria |
| 01/11/2012 | CN1930188B Estrogen receptors and methods of use |
| 01/11/2012 | CN102317319A Human antibodies aganist tissue factor. |
| 01/11/2012 | CN102317318A Anti-CD160 monoclonal antibodies and uses thereof |
| 01/11/2012 | CN102317317A Reagents for the atherosclerotic coronary plaque and uses thereof |
| 01/11/2012 | CN102317316A Human anti-alpha-synuclein autoantibodies |
| 01/11/2012 | CN102317311A Novel peptides and methods for producing them |
| 01/11/2012 | CN102311986A Cells producing antibody compositions |
| 01/11/2012 | CN102311499A Humanized monoclonal antibody for treating cancer, and preparation method and application thereof |
| 01/11/2012 | CN102311498A Method for separation of recombinant human antibody from transgenic mammal milk |
| 01/11/2012 | CN101953849B Method for preparing anti-duck viral hepatitis transfer factor |
| 01/11/2012 | CN101942414B Hybridoma cell line and chloramphenicol-resistant monoclonal antibody produced by same |
| 01/11/2012 | CN101899456B Tonoplast hydrogen pyrophosphatase gene of strong xerophyte zygophyllumxanthoxylum and plant expression vector as well as genetic plant transformation method thereof |
| 01/11/2012 | CN101775372B Anti-testicle-protein hT279 antibody or antibody fragment and application thereof |
| 01/11/2012 | CN101544962B EV virus wide spectrum monoclonal antibody and its uses |
| 01/11/2012 | CN101544695B Humanized anti-CD25 single-chain antibody and preparation method |
| 01/11/2012 | CN101326195B 抗il-17抗体 Anti-il-17 antibody |
| 01/11/2012 | CN101034090B Hepatitis E virus antibody and method and kit for detecting hepatitis E virus using same |
| 01/10/2012 | US8093450 Non-aggregating fluorescent proteins and methods for using the same |
| 01/10/2012 | US8093364 Enhanced purification of antibodies and antibody fragments by apatite chromatography |
| 01/10/2012 | US8093363 Tumor necrosis factor-gamma |
| 01/10/2012 | US8093362 p53 apoptosis effector related to PMP-22 (PERP) specific immunoglobulin for use in treatment and prevention of cell proliferative disorders |
| 01/10/2012 | US8093361 Anti-perp antibody |
| 01/10/2012 | US8093360 Antibodies that bind B. anthracis exotoxin, formulations thereof, and methods of use |
| 01/10/2012 | US8093359 Optimized Fc variants and methods for their generation |
| 01/10/2012 | US8093358 Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 01/10/2012 | US8093357 Optimized Fc variants and methods for their generation |
| 01/10/2012 | US8093068 Methods for use in human-adapting monoclonal antibodies |
| 01/10/2012 | US8093018 Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same |
| 01/10/2012 | US8093012 Multiplex in situ immunohistochemical analysis |
| 01/10/2012 | US8093010 Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer |
| 01/10/2012 | US8093006 Antibodies against human tweak and uses thereof |
| 01/10/2012 | US8092809 Pseudomonas exotoxin A-like chimeric immunogens |
| 01/10/2012 | US8092804 Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| 01/10/2012 | US8092799 Antibodies to Apo-2 receptor polypeptides |
| 01/10/2012 | US8092798 Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8 |
| 01/10/2012 | US8092797 using monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 01/10/2012 | US8092796 Monoclonal antibodies against ANGPTL4 |
| 01/10/2012 | US8092794 Pharmaceutical compositions comprising SODs and prolamine based peptide fragments |
| 01/10/2012 | CA2738176C Method for polyclonal immunoglobulin g production by human b cells |
| 01/10/2012 | CA2597701C Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype |
| 01/10/2012 | CA2528202C Process for recovering heterologous polypeptides from bacterial cells |
| 01/10/2012 | CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/10/2012 | CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/10/2012 | CA2388245C The use of serum-free adapted rat cells for producing heterologous polypeptides |
| 01/10/2012 | CA2214102C Group o hiv-1, fragments of such viruses, and uses thereof |
| 01/05/2012 | WO2012003493A2 Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use |
| 01/05/2012 | WO2012003472A1 Anti-notch1 antibodies |
| 01/05/2012 | WO2012003437A1 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 01/05/2012 | WO2012002745A2 Factor viia complex using an immunoglobulin fragment |
| 01/05/2012 | WO2012002345A1 Pivka-ii measurement method, pivka-ii measurement reagent, and antibody |
| 01/05/2012 | WO2012001674A1 Anti-ktpaf50 antibodies and their uses in therapeutic and diagnostic methods |
| 01/05/2012 | WO2012001142A1 Improved antibody binding affinity ligands |
| 01/05/2012 | WO2012001103A1 Histone citrullinated peptides and uses thereof |
| 01/05/2012 | WO2012001087A1 Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
| 01/05/2012 | WO2012000994A1 Llt-1 antibodies with new functional properties |
| 01/05/2012 | WO2012000889A1 Aptamers that inhibit interaction between antibody and 2nd extracellular loop of human beta-1-adrenergic receptor |
| 01/05/2012 | WO2012000094A1 REAGENTS AND METHODS FOR DIAGNOSING CONDITIONS ASSOCIATED WITH HYDROXYLATED HIF 1-α |
| 01/05/2012 | WO2012000062A1 Diagnosis and treatment of brain tumors |
| 01/05/2012 | WO2011143318A3 Anti-fgfr2 antibodies |
| 01/05/2012 | WO2011141823A3 Methods of treating and/or preventing cell proliferation disorders with il-17 antagonists |
| 01/05/2012 | WO2011135544A3 Methods and compositions for treating hepatitis with anti-cd3 immune molecule therapy |
| 01/05/2012 | WO2011122011A3 Antibodies with modified affinity to fcrn that promote antigen clearance |
| 01/05/2012 | WO2011106723A3 Anti-paf antibodies |
| 01/05/2012 | WO2011094593A3 Novel lowered affinity antibodies and methods of marking the same |
| 01/05/2012 | WO2011081366A9 Beef-specific age determination marker containing the p21 protein |
| 01/05/2012 | WO2010146420A8 Synthetic oligopeptides designed from mite cysteine proteases and methods for the production of igy polyclonal antibodies for the detection of intradomiciliary mites |
| 01/05/2012 | WO2002092832A9 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
| 01/05/2012 | US20120005767 Antibodies to insulin-like growth factor i receptor |
| 01/05/2012 | US20120005127 Methods for improvement of beta cell function |
| 01/05/2012 | US20120004643 Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells |
| 01/05/2012 | US20120004592 Compositions for solubilizing tissue |
| 01/05/2012 | US20120004397 Violet laser excitable dyes and their method of use |
| 01/05/2012 | US20120004289 Annexin a11 and associated genes as biomarkers for cancer |
| 01/05/2012 | US20120004183 Unnatural reactive amino acid genetic code additions |
| 01/05/2012 | US20120004179 Means and methods for manufacturing highly pure neurotoxin |
| 01/05/2012 | US20120004117 Diagnosis and treatment of cancer using anti-tm4sf20 antibody |
| 01/05/2012 | US20120003720 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same |
| 01/05/2012 | US20120003713 Polymerase Enhancing Factor (PEF) Extracts PEF Protein Complexes Isolated PEF Proteins and Methods for Purifying and Identifying |
| 01/05/2012 | US20120003696 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids, monoclonal antibodies specific to human hepcidin and associated uses therefor |
| 01/05/2012 | US20120003674 Chloral Hydrate Detection |
| 01/05/2012 | US20120003671 Methods for antibody engineering |
| 01/05/2012 | US20120003644 Methods and kits for determining predisposition to develop kidney diseases |
| 01/05/2012 | US20120003249 Immuno-molecules containing viral proteins, compositions thereof and methods of using |
| 01/05/2012 | US20120003248 Monomethylvaline compounds capable of conjugation to ligands |
| 01/05/2012 | US20120003247 Monomethylvaline compounds capable of conjugation to ligands |
| 01/05/2012 | US20120003246 Novel composition and methods for the treatment of psoriasis |
| 01/05/2012 | US20120003245 Anti-cobra toxin antibody fragments and method of producing a vhh library |
| 01/05/2012 | US20120003241 Vaccine against botulism |
| 01/05/2012 | US20120003237 Wise binding agents and epitopes |
| 01/05/2012 | US20120003236 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 01/05/2012 | US20120003235 Anti-lymphotoxin antibodies |
| 01/05/2012 | US20120003233 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor |